» Articles » PMID: 12932613

Asymptomatic Cardiac Disease Following Mediastinal Irradiation

Overview
Date 2003 Aug 23
PMID 12932613
Citations 116
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: This study was designed to evaluate the potential benefit of screening previously irradiated patients with echocardiography.

Background: Mediastinal irradiation is known to cause cardiac disease. However, the prevalence of asymptomatic cardiac disease and the potential for intervention before symptom development are unknown.

Methods: We recruited 294 asymptomatic patients (mean age 42 +/- 9 years, 49% men, mean mantle irradiation dose 43 +/- 0.3 Gy) treated with at least 35 Gy to the mediastinum for Hodgkin's disease. After providing written consent, each patient underwent electrocardiography and transthoracic echocardiography. Valvular disease was common and increased with time following irradiation. Patients who had received irradiation more than 20 years before evaluation had significantly more mild or greater aortic regurgitation (60% vs. 4%, p < 0.0001), moderate or greater tricuspid regurgitation (4% vs. 0%, p = 0.06), and aortic stenosis (16% vs. 0%, p = 0.0008) than those who had received irradiation within 10 years. The number needed to screen to detect one candidate for endocarditis prophylaxis was 13 (95% confidence interval [CI] 7 to 44) for patients treated within 10 years and 1.6 (95% CI 1.3 to 1.9) for those treated at least 20 years ago. Compared with the Framingham Heart Study population, mildly reduced left ventricular fractional shortening (<30%) was more common (36% vs. 3%), and age- and gender-adjusted left ventricular mass was lower (90 +/- 27 g/m vs. 117 g/m) in irradiated patients.

Conclusions: There is a high prevalence of asymptomatic heart disease in general, and aortic valvular disease in particular, following mediastinal irradiation. Screening echocardiography should be considered for patients with a history of mediastinal irradiation.

Citing Articles

Echocardiography and Heart Failure: An Echocardiographic Decision Aid for the Diagnosis and Management of Cardiomyopathies.

Pender A, Lewis-Owona J, Ekiyoyo A, Stoddard M Curr Cardiol Rep. 2025; 27(1):64.

PMID: 40019673 PMC: 11870920. DOI: 10.1007/s11886-025-02194-y.


Porcelain Aorta and Radiation-Induced Mitral Annular Calcification Are Not Contraindications to Surgery.

Okafor J, Thomson H, Ridge C, Lloyd G, Jakaj G, Prendergast B JACC Case Rep. 2025; 30(2):102725.

PMID: 39886400 PMC: 11775785. DOI: 10.1016/j.jaccas.2024.102725.


Cardiovascular mortality risk among small bowel adenocarcinoma patients: a population-based study.

Zhang Y, Zeng S, Wang Z, Zhu Q, Li J, Ren X BMC Public Health. 2025; 25(1):97.

PMID: 39780085 PMC: 11715972. DOI: 10.1186/s12889-025-21279-5.


An emerging double‑edged sword role of ferroptosis in cardiovascular disease (Review).

Qin S, Zhu C, Chen C, Sheng Z, Cao Y Int J Mol Med. 2024; 55(1).

PMID: 39540363 PMC: 11573318. DOI: 10.3892/ijmm.2024.5457.


Risk of Cardiovascular Disease in Patients With Classical Hodgkin Lymphoma: A Danish Nationwide Register-Based Cohort Study.

Godtfredsen S, Yonis H, Baech J, Al-Hussainy N, Riddersholm S, Kober L Eur J Haematol. 2024; 114(2):343-352.

PMID: 39501912 PMC: 11707824. DOI: 10.1111/ejh.14334.